Correlation Between Ginkgo Bioworks and Sana Biotechnology
Can any of the company-specific risk be diversified away by investing in both Ginkgo Bioworks and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ginkgo Bioworks and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ginkgo Bioworks Holdings and Sana Biotechnology, you can compare the effects of market volatilities on Ginkgo Bioworks and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ginkgo Bioworks with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ginkgo Bioworks and Sana Biotechnology.
Diversification Opportunities for Ginkgo Bioworks and Sana Biotechnology
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ginkgo and Sana is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Ginkgo Bioworks Holdings and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Ginkgo Bioworks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ginkgo Bioworks Holdings are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Ginkgo Bioworks i.e., Ginkgo Bioworks and Sana Biotechnology go up and down completely randomly.
Pair Corralation between Ginkgo Bioworks and Sana Biotechnology
Considering the 90-day investment horizon Ginkgo Bioworks Holdings is expected to generate 1.12 times more return on investment than Sana Biotechnology. However, Ginkgo Bioworks is 1.12 times more volatile than Sana Biotechnology. It trades about 0.1 of its potential returns per unit of risk. Sana Biotechnology is currently generating about -0.28 per unit of risk. If you would invest 784.00 in Ginkgo Bioworks Holdings on September 30, 2024 and sell it today you would earn a total of 182.00 from holding Ginkgo Bioworks Holdings or generate 23.21% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Ginkgo Bioworks Holdings vs. Sana Biotechnology
Performance |
Timeline |
Ginkgo Bioworks Holdings |
Sana Biotechnology |
Ginkgo Bioworks and Sana Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ginkgo Bioworks and Sana Biotechnology
The main advantage of trading using opposite Ginkgo Bioworks and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ginkgo Bioworks position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.The idea behind Ginkgo Bioworks Holdings and Sana Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |